The epidemiology of anaphylaxis in Europe: protocol for a systematic review

Clinical and Translational Allergy

Volumn 3, Issue 1, 2013, Pages 1-5

  Panesar, Sukhmeet S ^a   Nwaru, Bright I ^b   Hickstein, Lennart ^c   Rader, Tamara ^d   Hamadah, Hala ^e   Ali, Dana Fawzi Ibrahim ^e   Patel, Bhavesh ^f   Muraro, Antonella ^g   Roberts, Graham ^h   Worm, Margitta ⁱ   Sheikh, Aziz ^j  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF OTTAWA   (Canada)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f OPEN UNIVERSITY   (United Kingdom)

^g UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

Allergy; Anaphylaxis; Epidemiology; Incidence; Prevalence

Indexed keywords

ANAPHYLAXIS; ARTICLE; CASE FATALITY RATE; EUROPE; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 85006097738     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-3-9     Document Type: Article

References (22)

1. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier B, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: A revised nomenclature for allergy for global use: report of the nomenclature review committee of world allergy organization. J Allergy Clin Immunol. 2004, 113: 832-836. 10.1016/j.jaci.2003.12.591.
2. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, Moneret-Vautrin A, Niggemann B, Rancé F: EAACI task force on anaphylaxis in children. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007, 62 (8): 857-871. 10.1111/j.1398-9995.2007.01421.x.
3. American Academy of Pediatrics: Committee on school health. Guidelines for urgent care in school. Pediatrics. 1990, 86: 999-1000.
4. International Collaborative Study of Severe Anaphylaxis: An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology. 1998, 9: 141-146. 10.1097/00001648-199803000-00007.
5. Australasian Society of Clinical Immunology and Allergy Inc (ASCIA): Guidelines for EpiPen prescription. ASCIA Anaphylaxis Working Party. 2004, Available online at http://www.allergy.org.au/anaphylaxis/epipen_guidelines.htm Last accessed on 20th September 2012
6. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; and Joint Council of Allergy, Asthma, and Immunology: The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005, 115 (3 suppl): S483-S523.
7. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock A, Branum A, Brown SG, Camargo CA, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW: Second symposium on the definition and management of anaphylaxis: summary report-second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium. J Allergy Clin Immunol. 2006, 117: 391-397. 10.1016/j.jaci.2005.12.1303.
8. Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, Simons FE: Epidemiology of anaphylaxis: findings of the American college of allergy, asthma and immunology epidemiology of anaphylaxis working group. Ann Allergy Asthma Immunol. 2006, 97: 596-602. 10.1016/S1081-1206(10)61086-1.
9. Simons FE, Sheikh A: Evidence-based management of anaphylaxis. Allergy. 2007, 62: 827-829. 10.1111/j.1398-9995.2007.01433.x.
10. A dictionary of epidemiology. Edited by: Last JM. 2000, New York: Oxford University Press, 4
11. McMaster university health information research unit.http://hiru.mcmaster.ca/hiru/HIRU_Hedges_MEDLINE_Strategies.aspx#Reviews,
12. York University centre for reviews and dissemination.http://www.york.ac.uk/inst/crd/intertasc/epidemiological_studies.html,
13. McMaster filter for prognosis studies.http://hiru.mcmaster.ca/hiru/HIRU_Hedges_EMBASE_Strategies.aspx,
14. The organization for economic Co-operation and development.http://www.oecd.org/about/membersandpartners/,
15. OCEBM Levels of Evidence Working Group: The Oxford. 2011, Oxford Centre for Evidence-Based Medicine, Available online at http://www.cebm.net/index.aspx?o=5653 Last accessed on 28th September 2012, levels of evidence
16. CASP checklist for systematic reviews. http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Systematic_Review_Appraisal_Checklist_14oct10.pdf Last accessed on 10th October 2012
17. CASP checklist for cohort studies. http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Cohort_Appraisal_Checklist_14oct10.pdf Last accessed on 10th October 2012
18. CASP checklist for case-control studies. http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Case-Control_Appraisal_Checklist_14oct10.pdf Last accessed on 10th October 2012
19. Appraisal tools. http://www.casp-uk.net/ Last accessed on 20th September 2012
20. Effective public health practice project quality assessment tool. http://www.ephpp.ca/Tools.html Last accessed on 10th October 2012
21. Agresti A, Coull BA: Approximate is better than ‘exact' for interval estimation of binomial proportions. Am Statis. 1998, 52: 119-126.
22. Moher D, Liberati A, Tetzlaff J, Altman DG: The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6 (7): e1000097-10.1371/journal.pmed.1000097.